These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 15596957

  • 1. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS, Morillo CA, Connolly SJ.
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [Abstract] [Full Text] [Related]

  • 2. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 3. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH, Gollob M, Healey JS.
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [Abstract] [Full Text] [Related]

  • 4. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G, Schulz R.
    Dtsch Med Wochenschr; 2006 Apr 13; 131(15):817-20. PubMed ID: 16607602
    [Abstract] [Full Text] [Related]

  • 5. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
    Doğan A, Akçay S.
    Anadolu Kardiyol Derg; 2009 Dec 13; 9(6):505-11. PubMed ID: 19965325
    [Abstract] [Full Text] [Related]

  • 6. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S.
    Nat Clin Pract Cardiovasc Med; 2006 Apr 13; 3(4):220-5. PubMed ID: 16568131
    [Abstract] [Full Text] [Related]

  • 7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 13; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B, Derntl M, Marx M, Lercher P, Gössinger HD.
    Am Heart J; 2007 Jan 13; 153(1):113-9. PubMed ID: 17174648
    [Abstract] [Full Text] [Related]

  • 11. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP.
    Cardiol Rev; 2006 Jan 13; 14(2):81-7. PubMed ID: 16493245
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
    Zografos T, Katritsis DG.
    Pacing Clin Electrophysiol; 2010 Oct 13; 33(10):1270-85. PubMed ID: 20636314
    [Abstract] [Full Text] [Related]

  • 13. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS, Coleman CI, White CM.
    J Clin Pharmacol; 2006 Jan 13; 46(1):21-8. PubMed ID: 16397280
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
    Ozaydin M, Varol E, Türker Y, Peker O, Erdoğan D, Doğan A, Ibrişim E.
    Anadolu Kardiyol Derg; 2010 Apr 13; 10(2):137-42. PubMed ID: 20382613
    [Abstract] [Full Text] [Related]

  • 16. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U, Wollert KC, Drexler H.
    Cardiovasc Res; 2009 Feb 15; 81(3):519-27. PubMed ID: 19019834
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA, Flaa A, Strand A, Kjeldsen SE.
    J Hypertens; 2007 Jan 15; 25(1):15-23. PubMed ID: 17143167
    [Abstract] [Full Text] [Related]

  • 19. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
    Pichler M, Klein W, Huber K, Pachinger O.
    Wien Med Wochenschr; 1996 Jan 15; 146(11):228-31. PubMed ID: 8928520
    [Abstract] [Full Text] [Related]

  • 20. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C, Cosentino E, De Sanctis D.
    Ital Heart J Suppl; 2005 Dec 15; 6(12):769-79. PubMed ID: 16444921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.